Genetic privacy | medical privacy — The World Privacy Forum has published a new page on genetic privacy outlining basic policy issues and collecting World Privacy Forum work in the area. The page also links to key external research being done in privacy and genetics, and also links to key organizations doing work in this area in the U.S. and the U.K.
Medical privacy | Department of Transportation — The World Privacy Forum filed comments with the Department of Transportation today regarding the department’s publicationof the detailed personal medical information of individuals subject to DOT regulations in the Federal Register along with their names, ages, and other identifying information. The WPF comments argue that personal medical information combined with name, age, etc. does not belong in the Federal Register, where it can have potentially far-reaching consequences for those individuals who are named as well as their family members. The comment period closes April 2.
The World Privacy Forum filed comments with the Department of Transportation today regarding the department’s publication of the detailed personal medical information of individuals subject to DOT regulations in the Federal Register along with their names, ages, and other identifying information. The WPF comments argue that personal medical information combined with name, age, etc. does not belong in the Federal Register, where it can have potentially far-reaching consequences for those individuals who are named as well as their family members.
Genetic privacy | SACGHS — The World Privacy Forum gave testimony to the Secretary’s Advisory Committee on Genetics Health and Society regarding privacy issues stemming from direct-to-consumer advertising and consumer-initiated genetic testing. The World Privacy Forum noted that a great deal of consumer health data circulates outside the protections of HIPAA, and a substantial market for this kind of consumer health data already exists. Genetic data about consumers that is acquired outside the clinical context and is not subject to the protections of HIPAA (for example, through consumer-initiated genetic testing) will likely not be any more protected than other forms of consumers’ health-related information from the current demands of the market. However, the consequences of leakage of genetic information about consumers into the marketing stream could have potentially negative consequences for both those consumers and their blood relatives. The World Privacy Forum urged the committee to include specific recommendations about privacy in its upcoming report to the Secretary, and also urged the committee to work with other federal agencies to set up a pre-market oversight structure that includes significant and meaningful privacy protections for genetic testing occurring outside of the protections of HIPAA.
Genetic Privacy — The World Privacy Forum filed public comments with the Department of Health and Human services in response to an HHS request for information regarding the use of patients’ genetic data for research, health care, and for use in electronic health records. The World Privacy Forum is requesting that HHS use all Fair Information Principles in any personalized health care projects, and is requesting that a formal ELSI (ethical, legal, and social implications) committee be set up to oversee any projects, among other requests.
